Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Nucleoside analogs have revolutionized the field of antiviral drug development, offering potent therapeutic strategies against a wide array of viral infections. These compounds mimic natural nucleosides, acting as deceptive building blocks that interfere with viral replication processes, primarily by inhibiting viral DNA or RNA polymerases. Their profound impact is evident in treatments for HIV, hepatitis, and various herpesvirus infections, where they have significantly improved patient outcomes. A prime example of this class of antivirals is Cidofovir Anhydrous.
The mechanism of action of nucleoside analogs is elegantly simple yet highly effective. Once incorporated into the viral genome, they can lead to premature chain termination or produce faulty viral nucleic acids, thereby halting replication. Cidofovir Anhydrous, specifically, is an acyclic nucleoside phosphonate that exerts its antiviral effect by selectively inhibiting viral DNA synthesis. This selective action minimizes harm to host cells while effectively targeting the pathogen.
The development of nucleoside analogs like Cidofovir Anhydrous for CMV retinitis and other herpesvirus infections represents a major breakthrough. Its efficacy against human cytomegalovirus (HCMV), as well as activity against HSV, VZV, and even acyclovir-resistant herpes, highlights its versatility and importance in clinical practice. As a high-quality antiviral API, Cidofovir Anhydrous CAS 113852-37-2 is a critical component for pharmaceutical companies engaged in producing effective antiviral medications.
Future antiviral drug development trends continue to explore new nucleoside analogs and refine existing ones, aiming for improved potency, reduced toxicity, and broader spectrum activity. The ongoing research into the selective viral DNA synthesis inhibition mechanisms ensures that these compounds remain at the forefront of infectious disease therapeutics. NINGBO INNO PHARMCHEM CO.,LTD., a dedicated Cidofovir Anhydrous manufacturer, contributes to this progress by supplying this vital API to research institutions and pharmaceutical producers globally.
For those looking to buy Cidofovir Anhydrous API or other nucleoside analogs for their research or manufacturing needs, partnering with a reliable Cidofovir Anhydrous supplier like NINGBO INNO PHARMCHEM CO.,LTD. is crucial. We offer a competitive price for Cidofovir Anhydrous while ensuring the highest purity and adherence to pharmaceutical-grade standards, thereby supporting the continuous evolution of antiviral therapies and combating infectious diseases more effectively.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
